Our 2026 – 2027 Plan

Core Priorities

As a cancer alliance, our core ambitions sit in line with the National Cancer Plan, which aims to:

  • meet the Cancer Waiting Time standards by the end of this Parliament
  • see three in four people diagnosed with cancer be cancer-free or living well with cancer after five years by 2035
  • improve the quality of life for people being diagnosed with, treated for, or living with cancer

The key ambitions will be achieved through multi-organisational collaboration, innovation, and empowering patients and the public. 

Our Work Programmes

Cancer Performance and Pathway Improvement

Purpose: To drive measurable improvement in cancer operational performance
across SWAG by providing targeted, data‑driven support to providers,
reducing pathway variation, and accelerating adoption of best practice
to deliver faster diagnosis, timely treatment and improved outcomes.

  • Targeted support for providers performing in the bottom national quartile against 28‑day FDS, 31‑day and 62‑day standards.
  • Aim: 10 percentage point improvement up to national targets (FDS 80%, 31‑day 94%, 62‐day 80%).
  • Focus pathways: Breast, Skin, Urology, Gynaecology, Lower GI.
  • Treatment focus: Lung, Oesophageal cancer surgery, Kidney cancer.
  • Support includes data intelligence, co‑designed improvement plans, targeted funding, Best Practice Timed Pathway roll‑out, deep‑dive diagnostics, digital pathway tracking and enhanced peer review.

Neighbourhood Early Diagnosis

Purpose: To increase early diagnosis of cancer, reduce late‑stage presentation, and achieve earlier access to timely investigation through neighbourhood‑based,community‑centred models that strengthen primary care, improve screening uptake, increase symptom awareness, and embed innovation.

  • Priority tumour groups: 
    • High incidence/poor Early Diagnosis
    • Less survivable and Rare Cancers
    • Deprivation gaps
  • Primary Care pathways: leadership, education, equity in straight‑to‑test, referral audits, QI funding.
  • Innovation: self‑referral pilots, case‑finding, Capsule Sponge roll‑out.
  • Screening: HPV self sampling, non‑responder audits, coordinated screening network, 100% coverage LCS
  • Timely presentation: local campaigns, Cancer Champions, small grants.
  • Prevention: Making Every Contact Count, HPV vaccine awareness, community prevention mapping.

Neighbourhood Cancer Care

Purpose: To deliver personalised, holistic cancer care closer to home, improving patient experience, supporting people to live well with and beyond cancer, and ensuring care pathways reflect individual needs. The programme expands Personalised Stratified Follow‑Up (PSFU), strengthens personalised care, and enhances supportive care across SWAG.

  • Personal Stratified Follow-Up (PSFU) expansion to 8 pathways by 2029; at least one new pathway implemented in 2026–27.
  • Increased use of Remote Monitoring Systems (RMS) with focus on equity and sustainability.
  • Strengthen data quality for HNA, PCSP and EoTS; develop LWBC dashboard.
  • Expand psychosocial support capacity; standardise CSW training; improve Level 2 psychological skills.
  • Implement Prehabilitation improvement plan and Physical Activity programme across SWAG.
  • Address inequities in supportive care, rehabilitation and late effects services.

Treatment Variation

Purpose: To reduce unwarranted variation in cancer treatment across SWAG by implementing national clinical audit and GIRFT recommendations, ensuring patients receive evidence‑based, timely, and equitable treatment regardless of provider. Work focuses on improving treatment uptake in key tumour groups where variation is contributing to poorer outcomes.

​Implement national GIRFT/clinical audit recommendations targeting:

  • Lung SACT uptake
  • Bowel adjuvant chemotherapy
  • Primary breast immediate reconstruction
  • Ovarian treatment rates
  • Pancreatic disease‑targeted treatment
  • Includes named clinical leads and integration with Clinical Advisory Groups.

Cross-cutting​

Workforce

  • ​Embed ACCEND framework across nursing, AHP and support roles.
  • Strengthen diagnostic workforce (LATP, nurse endoscopy, teledermatology).
  • Standardise CSW induction; develop consistent CNS role standards.
  • Support training, student placements, digital portfolios and cancer‑specific competency development.​

Innovation & Digital Transformation

  • Complete digital maturity assessments across SWAG.
  • Develop digital implementation plan aligned to National Cancer Plan.
  • Support roll‑out of national digital tooling via the Federated Data Platform (e.g., Cancer 360).
  • Embed innovation culture via SWAG Innovates Together Forum

Organisational Development and Engagement

  • Strengthen leadership, shared purpose and team effectiveness.
  • Align Early Diagnosis and Treatment & Care teams to drive neighbourhood working.
  • Enhance communications & engagement
  • Systematic capture and use of patient insight (CPES, U16 CPES, PALS, complaints).

Health Inequalities

All activity within this plan is underpinned by a commitment to tackling health inequalities, ensuring equitable access, experience and outcomes for all communities.

 

Enablers and partners

  • Our Workforce
  • Patient involvement and engagement
  • Clinical Advisory Groups 
  • Clinical Leadership Forums
  • Digital and Diagnostic Teams